University of Leicester research sheds light on how bacteria regulates metabolism which could help to combat infectious diseases including tuberculosis. University of Leicester researchers have shed new light on how bacteria sense nutrients in their environment - which could provide important knowledge in the development of drugs and antibiotics to combat a range of diseases including tuberculosis...
Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical community. As part of the agreement, Oxford Genetics will leverage its high throughput automated genomic engineering platform for CRISPR modification of mammalian cell lines...
Research published in Nature Medicine describes collaborative effort to reduce off-target CRISPR-Cas9 genome editing – removing barriers for human therapeutic applications. Genome editing using the CRISPR-Cas9 system has tremendous promise for therapeutic correction of genetic errors in human cells. Prior to adoption as a medical therapeutic, safety concerns relating to off-target effects must be minimized to...
Hot on the Trail of the Biostability of Water Using State-of-the-Art DNA and Cell Analysis. Karl Landsteiner University of Health Sciences in Krems launches project to study the growth of water-based microorganisms. In order to better understand and assess the quality of ground and spring water, state-of-the-art...
Library website of real-world observational studies in cardiometabolic medicine is launched. A new Leicester initiative is providing access to reliable information in the field of cardiometabolic medicine. Leicester Real World Evidence Unit, headed by Professor Kamlesh Khunti at the Diabetes Research Centre, has launched ERICAS, a library website of real-world observational studies in...
A landmark study published in the journal Brain from the Mario Negri Institute for Pharmacological Research of Milan and the University of Glasgow provides first evidence that just a single traumatic brain injury can generate an abnormal form of the dementia associated protein tau that can slowly spread through the brain, resulting in memory deficits and neuronal damage. “Traumatic brain injury is a leading cause of death and...
“The assignment is an essential milestone in our ambition to increase our presence in the Healthcare industry. The winning bid proves that our innovative approach provides great benefits to organizations like RIVM in their search for a more flexible, configurable and future-proof NHS LIMS. As our system is based on the latest technologies it offers unrestricted scalability and brings down the total cost of ownership”, says Oscar Kox, CEO of iVention....
Drug conjugate combines Avacta’s Affimer technology with drug conjugates developed at Tufts. Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has agreed a co-development partnership with Bach BioSciences, a company commercialising the research of William Bachovchin, Professor of Developmental...
Yumizen H500 full blood count analyser demonstrates exceptional correlation with larger laboratory-based. HORIBA UK Ltd, Medical announces the publication of two studies successfully evaluating the use of its Yumizen H500 haematology analyser for point-of-care testing (POCT) to enhance the care of oncology patients. With near-patient, full blood count results, patients undergoing chemotherapy can receive treatment without delay and...
Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance. Phico Therapeutics Ltd, a biotechnology company developing a novel platform technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, today announced that it had been awarded...
Linkam Scientific Instruments, reports on the research of Dr Jamie Wilkinson of the Natural History Museum in London where he uses temperature-controlled microscopy to characterize mineral deposits. Dr Jamie Wilkinson is a Research Leader in Mineral Deposits in the Department of Earth Sciences at the Natural History Museum, London. He is a member of the London Centre for Ore Deposits and Exploration (LODE) Research Group...
Promega UK, the Life Sciences Company, based on the University of Southampton Science Park in Hampshire, has announced the winners of its first Helix Sustainability award. Helix is an onsite RFID (Radio Frequency Identification) laboratory storage system used to support scientists with their life sciences research fighting diseases such as Cancer and Alzheimer’s....
After months in development flow chemistry engineering specialists Vapourtec have provided a prototype electrochemical reactor to Dr Thomas Wirth, Professor of Organic Chemistry at Cardiff University, for evaluation. The latest prototype offers a range of exciting features that will be implemented in the production versions including temperature control and operation...
Immunotherapy is the use of a patient's own immune system to treat disease and is one of the most promising new therapies in the fight against cancer. Cancer cells invade the body's immune system, but they are similar to normal, healthy cells and can hide from the immune system and spread. In cancer immunotherapy or immuno-oncology, a patient's immune system is ‘activated' to fight cancer...
A South Australian university has recruited a leading quantum physics expert in a bid to win the race to build the world’s first quantum battery. Dr James Quach has joined the University of Adelaide’s School of Physical Sciences for four years under a Ramsay Fellowship. He will work within the Precision Measurement Group in the University’s Institute for Photonics and Advanced Sensing (IPAS)...
Weighing requires accuracy, especially when the readability of a balance reaches 0,01mg or more. However, in many applications the samples being weighed might be harmful or dangerous for the operator and the use of a fume hood is required in order to protect the laboratory personnel. Air flow, drafts and vibrations can adversely affect the weighing performance of any balance and eventually cause errors to the measurement....
Shimadzu’s state-of-the-art technology and expertise in gas sampling has enabled it to develop a bespoke Nexis GC-2030 for Celtic Recycling in Newport, Gwent, allowing the company to introduce GC screening of reclaimed and recycled SF6 gas, a service that no other company in the UK is currently able to offer. At the same time, the new system increased the laboratory’s capacity for the analysis...
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on how the Nano Imaging Lab of the Swiss Nanoscience Institute uses JPK’s versatile NanoWizard® 4 AFM system. Dr Monica Schönenberger has developed a flexible, professional service unit for atomic force microscopy. As a member of the Swiss Nanoscience Institute (SNI)...
Immunotherapy is the use of a patient's own immune system to treat disease and is one of the most promising new therapies in the fight against cancer. Cancer cells invade the body's immune system, but they are similar to normal, healthy cells and can hide from the immune system and spread. In cancer immunotherapy or immuno-oncology, a patient's immune system is ‘activated' to fight cancer...
MR Solutions has installed Hawaii’s first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research. This is very good news for Hawaii which has a very high incidence of kidney disease - one in seven residents on the island has chronic kidney disease....
Newly published findings may lead to more personalized prostate cancer therapies. A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research in the United States. The findings may provide important information for identifying which patients potentially fare better when treated with a different therapy...
The contract is related to interaction characterization of therapeutic antibodies using Attana’s cell-based technology. The order value is approximately 300 kSEK and will have a positive effect of the cash flow and results during Q3 2018. Attana’s application specialists will perform interaction analysis assays....
University of Leicester research sheds light on how bacteria regulates metabolism which could help to combat infectious diseases including tuberculosis. University of Leicester researchers have shed new light on how bacteria sense nutrients in their environment - which could provide important knowledge in the development of drugs and antibiotics to combat a range of diseases including tuberculosis...
Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical community. As part of the agreement, Oxford Genetics will leverage its high throughput automated genomic engineering platform for CRISPR modification of mammalian cell lines...
Research published in Nature Medicine describes collaborative effort to reduce off-target CRISPR-Cas9 genome editing – removing barriers for human therapeutic applications. Genome editing using the CRISPR-Cas9 system has tremendous promise for therapeutic correction of genetic errors in human cells. Prior to adoption as a medical therapeutic, safety concerns relating to off-target effects must be minimized to...
Hot on the Trail of the Biostability of Water Using State-of-the-Art DNA and Cell Analysis. Karl Landsteiner University of Health Sciences in Krems launches project to study the growth of water-based microorganisms. In order to better understand and assess the quality of ground and spring water, state-of-the-art...
A landmark study published in the journal Brain from the Mario Negri Institute for Pharmacological Research of Milan and the University of Glasgow provides first evidence that just a single traumatic brain injury can generate an abnormal form of the dementia associated protein tau that can slowly spread through the brain, resulting in memory deficits and neuronal damage. “Traumatic brain injury is a leading cause of death and...
“The assignment is an essential milestone in our ambition to increase our presence in the Healthcare industry. The winning bid proves that our innovative approach provides great benefits to organizations like RIVM in their search for a more flexible, configurable and future-proof NHS LIMS. As our system is based on the latest technologies it offers unrestricted scalability and brings down the total cost of ownership”, says Oscar Kox, CEO of iVention....
Drug conjugate combines Avacta’s Affimer technology with drug conjugates developed at Tufts. 
Yumizen H500 full blood count analyser demonstrates exceptional correlation with larger laboratory-based. HORIBA UK Ltd, Medical announces the publication of two studies successfully evaluating the use of its Yumizen H500 haematology analyser for point-of-care testing (POCT) to enhance the care of oncology patients. With near-patient, full blood count results, patients undergoing chemotherapy can receive treatment without delay and...
Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance. Phico Therapeutics Ltd, a biotechnology company developing a novel platform technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, today announced that it had been awarded...
Linkam Scientific Instruments, reports on the research of Dr Jamie Wilkinson of the Natural History Museum in London where he uses temperature-controlled microscopy to characterize mineral deposits. Dr Jamie Wilkinson is a Research Leader in Mineral Deposits in the Department of Earth Sciences at the Natural History Museum, London. He is a member of the London Centre for Ore Deposits and Exploration (LODE) Research Group...
Promega UK, the Life Sciences Company, based on the University of Southampton Science Park in Hampshire, has announced the winners of its first Helix Sustainability award. Helix is an onsite RFID (Radio Frequency Identification) laboratory storage system used to support scientists with their life sciences research fighting diseases such as Cancer and Alzheimer’s....
After months in development flow chemistry engineering specialists Vapourtec have provided a prototype electrochemical reactor to Dr Thomas Wirth, Professor of Organic Chemistry at Cardiff University, for evaluation. The latest prototype offers a range of exciting features that will be implemented in the production versions including temperature control and operation...
Immunotherapy is the use of a patient's own immune system to treat disease and is one of the most promising new therapies in the fight against cancer. Cancer cells invade the body's immune system, but they are similar to normal, healthy cells and can hide from the immune system and spread. In cancer immunotherapy or immuno-oncology, a patient's immune system is ‘activated' to fight cancer...
A South Australian university has recruited a leading quantum physics expert in a bid to win the race to build the world’s first quantum battery. Dr James Quach has joined the University of Adelaide’s School of Physical Sciences for four years under a Ramsay Fellowship. He will work within the Precision Measurement Group in the University’s Institute for Photonics and Advanced Sensing (IPAS)...
Weighing requires accuracy, especially when the readability of a balance reaches 0,01mg or more. However, in many applications the samples being weighed might be harmful or dangerous for the operator and the use of a fume hood is required in order to protect the laboratory personnel. Air flow, drafts and vibrations can adversely affect the weighing performance of any balance and eventually cause errors to the measurement....
Shimadzu’s state-of-the-art technology and expertise in gas sampling has enabled it to develop a bespoke Nexis GC-2030 for Celtic Recycling in Newport, Gwent, allowing the company to introduce GC screening of reclaimed and recycled SF6 gas, a service that no other company in the UK is currently able to offer. At the same time, the new system increased the laboratory’s capacity for the analysis...
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on how the Nano Imaging Lab of the Swiss Nanoscience Institute uses JPK’s versatile NanoWizard® 4 AFM system. Dr Monica Schönenberger has developed a flexible, professional service unit for atomic force microscopy. As a member of the Swiss Nanoscience Institute (SNI)...
Immunotherapy is the use of a patient's own immune system to treat disease and is one of the most promising new therapies in the fight against cancer. Cancer cells invade the body's immune system, but they are similar to normal, healthy cells and can hide from the immune system and spread. In cancer immunotherapy or immuno-oncology, a patient's immune system is ‘activated' to fight cancer...
MR Solutions has installed Hawaii’s first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research. This is very good news for Hawaii which has a very high incidence of kidney disease - one in seven residents on the island has chronic kidney disease....
Newly published findings may lead to more personalized prostate cancer therapies. A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research in the United States. The findings may provide important information for identifying which patients potentially fare better when treated with a different therapy...
The contract is related to interaction characterization of therapeutic antibodies using Attana’s cell-based technology. The order value is approximately 300 kSEK and will have a positive effect of the cash flow and results during Q3 2018. Attana’s application specialists will perform interaction analysis assays....